ZIMHI
- Product NDC
- 38739-600
- 11-digit product format
- 387390600
- Labeler code
- 38739
- Product ID
- 38739-600_7dccaf6e-19d0-4720-aac3-c2500a760575
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Naloxone Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; SUBCUTANEOUS
- Labeler
- Adamis Pharmaceuticals
- Application
- NDA212854
- Marketing category
- NDA
- Marketing start
- 2022-01-15
- Marketing end
- 0000-00-00
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 5 mg/.5mL
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 38739-600-01 | 38739060001 | 1 SYRINGE in 1 CONTAINER (38739-600-01) > .5 mL in 1 SYRINGE | 1 syringe | 2022-01-15 | 0000-00-00 | No | No | Current |
| 38739-600-02 | 38739060002 | 2 SYRINGE in 1 CONTAINER (38739-600-02) > .5 mL in 1 SYRINGE | 2 syringe | 2022-01-15 | 0000-00-00 | No | No | Current |